IC
IEQ Capital Portfolio holdings
AUM
$16.3B
1-Year Return
39.51%
This Quarter Return
+25.09%
1 Year Return
+39.51%
3 Year Return
+152.4%
5 Year Return
+193.99%
10 Year Return
–
AUM
$16.3B
AUM Growth
+$3.77B
(+30%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
2,029
New
422
Increased
852
Reduced
463
Closed
222
Top Buys
| 1 |
NVIDIA
NVDA
|
+$131M |
| 2 |
Upbound Group
UPBD
|
+$95.4M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$75.2M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$51.3M |
| 5 |
Arista Networks
ANET
|
+$35.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
Apollo Global Management
APO
|
+$70.2M |
| 3 |
Carvana
CVNA
|
+$59.1M |
| 4 |
PDX
PIMCO Dynamic Income Strategy Fund
PDX
|
+$51.3M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$45.8M |
Sector Composition
| 1 | Technology | 24.35% |
| 2 | Communication Services | 20.35% |
| 3 | Financials | 9.77% |
| 4 | Consumer Discretionary | 8% |
| 5 | Healthcare | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
NeoGenomics
NEO
$966M
| $184K | ﹤0.01% |
+25,233
| New | +$184K |
|
1627
BlackRock CA Municipal Income Trust
BFZ
$328M
| $182K | ﹤0.01% |
16,875
-1,320,234
| -99% | -$14.3M |
|
1628
Hafnia
HAFN
$3.06B
| $182K | ﹤0.01% |
36,538
+712
| +2% | +$3.55K |
|
1629
Lexicon Pharmaceuticals
LXRX
$392M
| $182K | ﹤0.01% |
192,101
+14,799
| +8% | +$14K |
|
1630
Day One Biopharmaceuticals
DAWN
$744M
| $182K | ﹤0.01% |
27,948
-9,064
| -24% | -$58.9K |
|
1631
American Axle
AXL
$704M
| $178K | ﹤0.01% |
+43,685
| New | +$178K |
|
1632
Zymeworks
ZYME
$1.15B
| $178K | ﹤0.01% |
+14,169
| New | +$178K |
|
1633
James River Group
JRVR
$246M
| $175K | ﹤0.01% |
29,892
-4,259
| -12% | -$25K |
|
1634
Stellantis
STLA
$25.3B
| $175K | ﹤0.01% |
+17,400
| New | +$175K |
|
1635
ICL Group
ICL
$8.07B
| $174K | ﹤0.01% |
25,336
-381
| -1% | -$2.62K |
|
1636
Alignment Healthcare
ALHC
$3.26B
| $174K | ﹤0.01% |
12,426
-13,434
| -52% | -$188K |
|
1637
American Eagle Outfitters
AEO
$3.34B
| $174K | ﹤0.01% |
18,036
-125,655
| -87% | -$1.21M |
|
|
NBXG
1638
Neuberger Berman Next Generation Connectivity Fund
NBXG
$1.19B
| $173K | ﹤0.01% |
11,880
-673,395
| -98% | -$9.83M |
|
1639
Adaptive Biotechnologies
ADPT
$1.89B
| $173K | ﹤0.01% |
14,874
-34,476
| -70% | -$402K |
|
1640
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.64B
| $173K | ﹤0.01% |
14,462
| – | – |
|
1641
Recursion Pharmaceuticals
RXRX
$1.98B
| $172K | ﹤0.01% |
34,048
-19,180
| -36% | -$97.1K |
|
1642
Sunrun
RUN
$3.74B
| $171K | ﹤0.01% |
20,951
-6,775
| -24% | -$55.4K |
|
1643
Inogen
INGN
$225M
| $170K | ﹤0.01% |
24,217
+5,539
| +30% | +$38.9K |
|
1644
Zeta Global
ZETA
$4.49B
| $168K | ﹤0.01% |
+10,829
| New | +$168K |
|
1645
Nomura Holdings
NMR
$21.9B
| $167K | ﹤0.01% |
25,448
+4,366
| +21% | +$28.7K |
|
1646
Aegon
AEG
$12B
| $167K | ﹤0.01% |
23,109
+7,316
| +46% | +$53K |
|
1647
QuinStreet
QNST
$912M
| $167K | ﹤0.01% |
+10,374
| New | +$167K |
|
1648
Larimar Therapeutics
LRMR
$342M
| $165K | ﹤0.01% |
57,261
+40,801
| +248% | +$118K |
|
|
VERV
1649
DELISTED
Verve Therapeutics
VERV
| $164K | ﹤0.01% |
14,648
-54,522
| -79% | -$612K |
|
1650
Vipshop
VIPS
$8.85B
| $161K | ﹤0.01% |
+10,715
| New | +$161K |
|